Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

This study has been completed.

Study NCT00002429 Information provided by Bristol-Myers Squibb

First Received: November 2, 1999 Last Updated: April 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2001
Primary Completion Date:	January 2001 (Final data collection date for primary outcome measure)